CAS No. |
859-18-7 |
中文名称 |
(2S,4R)-N-((1R,2R)-2-羟基-1-((2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(甲硫基)四氢-2H-吡喃-2-基)丙基)-1-甲基-4-丙基吡咯烷-2-甲酰胺盐酸盐 |
英文名称 |
(2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride |
别名 |
METHYL 6,8-DIDEOXY-6-(1-METHYL-4-PROPYL-2-PYRROLIDINECARBOXAMIDO)-1-THIO-D-ERYTHRO-ALPHA-D-GALACTOOCTOPYRANOSIDE HYDROCHLORIDE;LINCOMYCIN HCL;LINCOMYCIN HYDROCHLORIDE;LINCOCIN HYDROCHLORIDE;lincomycin standard solution;ALPHA-METHYL-6,8-DIDEOXY-6-[1-METHYL-4-PROPYL-2-PYRROLIDINECARBOXAMIDO]-1-THIO-D-ERYTHRO-D-GALACTOOCTOPYRANOSIDE HYDROCHLORIDE;U-10149A;N-[2-HYDROXY-1-(3,4,5-TRIHYDROXY-6-METHYLSULFANYL-OXAN-2-YL)-PROPYL]-1-METHYL-4-PROPYL-PYRROLIDINE-2-CARBOXAMIDE |
标准英文名 |
(2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride |
分子式 |
C18H34N2O6S.ClH |
分子量 |
442.19
|
精确分子量 |
442.19
|
SMILES |
O=C([C@@H]1C[C@H](CN1C)CCC)N[C@@H]([C@@]2([H])O[C@@H]([C@@H]([C@H]([C@H]2O)O)O)SC)[C@H](O)C.Cl |
标准SMILES |
Cl.C[C@@H](O)[C@@H](NC(=O)[C@@H]1C[C@@H](CCC)CN1C)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O |
用途 |
Lincomycin hydrochloride is an antibiotic used to treat infections caused by Gram-positive bacteria, particularly those resistant to penicillin, as well as Mycoplasma infections in poultry (chronic respiratory disease) and swine (enzootic pneumonia), and anaerobic bacterial infections such as necrotic enteritis in chickens. It is also indicated for swine dysentery caused by Brachyspira hyodysenteriae, toxoplasmosis, and actinomycosis in dogs and cats. Clinically, it is used for sepsis, female genital tract infections, endometritis, tubo-ovarian abscesses, pelvic cellulitis, postoperative vaginal and adnexal infections, peritonitis, abscesses, pneumonia, lung abscesses, and skin and soft tissue infections caused by susceptible Gram-positive and certain anaerobic bacteria. It is additionally used for streptococcal and staphylococcal sepsis, bone and joint infections, surgical adjunctive therapy for chronic osteoarticular infections, acute hematogenous osteomyelitis caused by Staphylococcus aureus, and infections caused by methicillin-resistant Staphylococcus aureus (MRSA). It is also an alternative for patients allergic or intolerant to penicillins. Topically, it treats purulent infections caused by Gram-positive bacteria. |
InChIKey |
POUMFISTNHIPTI-BOMBIWCESA-N |